This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

CME eReport

Lessening the Side Effect Burden to Improve Adherence Among Individuals With Schizophrenia

John M. Kane, MD

Published: March 23, 2021

In the treatment of schizophrenia, whereas clinicians tend to put great emphasis on symptom resolution and functioning as treatment goals, patients put greater value on well-being and quality of life. Many patients may experience more distress related to adverse effects than clinicians realize. Adverse effects are a frequent reason for nonadherence, which may lead to negative treatment outcomes, including structural brain changes, worsening symptoms, and increased treatment resistance when medication is resumed. By evaluating adherence and patients’ reasons for nonadherence, clinicians can try to address problems such as adverse events that prevent patients from maintaining their medication regimens.

See the entire activity

To cite: Kane JM. Lessening the side effect burden to improve adherence among individuals with schizophrenia. J Clin Psychiatry. 2021;82(2):IC20018BR1C.
To share:

© Copyright 2021 Physicians Postgraduate Press, Inc.

From the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York.

Volume: 82

Quick Links: Schizophrenia and Schizoaffective Disorders


Sign-up to stay
up-to-date today!


Already registered? Sign In

Original Research

Young-Adult Social Outcomes of Attention-Deficit/Hyperactivity Disorder

ADHD that persisted into young-adulthood was associated with poorer outcomes in terms of education, employment, and emotional...